Invesco Ltd. Gsk PLC Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$42.05 - $47.77 $150,791 - $171,303
3,586 Added 55.87%
10,004 $435,000
Q1 2022

May 16, 2022
BUY
$40.23 - $47.74 $16,655 - $19,764
414 Added 6.9%
6,418 $280,000
Q4 2021

Feb 14, 2022
SELL
$38.88 - $45.31 $623,751 - $726,908
-16,043 Reduced 72.77%
6,004 $265,000
Q3 2021

Nov 15, 2021
BUY
$38.79 - $43.16 $634,061 - $705,493
16,346 Added 286.72%
22,047 $842,000
Q2 2021

Aug 17, 2021
SELL
$36.52 - $41.46 $191,182 - $217,043
-5,235 Reduced 47.87%
5,701 $227,000
Q1 2021

May 17, 2021
SELL
$34.27 - $40.01 $1.05 Million - $1.22 Million
-30,518 Reduced 73.62%
10,936 $390,000
Q4 2020

Feb 16, 2021
BUY
$34.07 - $39.94 $260,431 - $305,301
7,644 Added 22.61%
41,454 $1.53 Million
Q3 2020

Nov 16, 2020
SELL
$38.11 - $42.99 $176,068 - $198,613
-4,620 Reduced 12.02%
33,810 $1.27 Million
Q2 2020

Aug 14, 2020
SELL
$37.87 - $43.58 $22.5 Million - $25.9 Million
-594,139 Reduced 93.92%
38,430 $1.57 Million
Q1 2020

May 15, 2020
SELL
$32.47 - $48.83 $280,345 - $421,598
-8,634 Reduced 1.35%
632,569 $24 Million
Q4 2019

Feb 14, 2020
SELL
$42.0 - $48.25 $227,682 - $261,563
-5,421 Reduced 0.84%
641,203 $30.1 Million
Q3 2019

Nov 14, 2019
BUY
$40.46 - $43.52 $92,774 - $99,791
2,293 Added 0.36%
646,624 $27.6 Million
Q2 2019

Aug 14, 2019
BUY
$39.4 - $42.7 $21.2 Million - $22.9 Million
537,370 Added 502.4%
644,331 $25.8 Million
Q1 2019

May 15, 2019
SELL
$38.57 - $42.69 $837,817 - $927,312
-21,722 Reduced 16.88%
106,961 $4.47 Million
Q4 2018

Feb 14, 2019
BUY
$37.8 - $42.69 $4.86 Million - $5.49 Million
128,683 New
128,683 $4.92 Million

Others Institutions Holding GSK

# of Institutions
20
Shares Held
176K
Call Options Held
0
Put Options Held
0
View Full List

About GSK PLC

GSK Quotes by TradingView
  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email